Filing Details

Accession Number:
0001077183-25-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-13 16:05:28
Reporting Period:
2025-05-11
Filing Date:
2025-05-13
Accepted Time:
2025-05-13 16:05:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1955295 Warren Stone 9490 Neogenomics Way
Fort Myers FL 33912
Pres & Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-11 9,613 $0.00 104,921 No 4 M Direct
Common Stock Disposition 2025-05-11 2,341 $0.00 102,580 No 4 F Direct
Common Stock Acquisiton 2025-05-12 5,700 $8.58 108,280 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2025-05-11 9,613 $0.00 9,613 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,613 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $11.21 2029-12-01 166,113 166,113 Direct
Common Stock Stock Option (Right to Buy) $19.65 2030-05-11 53,969 53,969 Direct
Common Stock Performance Stock Unit $0.00 2026-05-11 21,204 21,204 Direct
Common Stock Stock Option (Right to Buy) $16.45 2034-02-23 42,344 42,344 Direct
Common Stock Restricted Stock Unit $0.00 16,886 16,886 Direct
Common Stock Performance Stock Unit $0.00 2027-02-23 25,330 25,330 Direct
Common Stock Stock Option (Right to Buy) $13.96 2034-05-02 29,976 29,976 Direct
Common Stock Restricted Stock Unit $0.00 17,908 17,908 Direct
Common Stock Performance Stock Unit $0.00 2027-05-02 17,908 17,908 Direct
Common Stock Restricted Stock Unit $0.00 2026-01-13 59,382 59,382 Direct
Common Stock Stock Option (Right to Buy) $13.05 2035-02-21 143,266 143,266 Direct
Common Stock Restricted Stock Unit $0.00 84,317 84,317 Direct
Common Stock Stock Option (Right to Buy) $10.44 2035-04-01 94,518 94,518 Direct
Common Stock Restricted Stock Unit $0.00 52,687 52,687 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-12-01 166,113 166,113 Direct
2030-05-11 53,969 53,969 Direct
21,204 21,204 Direct
2034-02-23 42,344 42,344 Direct
16,886 16,886 Direct
25,330 25,330 Direct
2034-05-02 29,976 29,976 Direct
17,908 17,908 Direct
17,908 17,908 Direct
59,382 59,382 Direct
2035-02-21 143,266 143,266 Direct
84,317 84,317 Direct
2035-04-01 94,518 94,518 Direct
52,687 52,687 Direct
Footnotes
  1. Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
  2. Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
  3. On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
  4. Once vested, the shares of common stock are not subject to expiration.
  5. On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  6. On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  7. On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
  8. On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  9. On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
  10. On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  11. On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  12. On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
  13. On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  14. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
  15. On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  16. On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  17. This stock option was granted as a premnium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
  18. On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  19. On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.